Biocom

147 articles about Biocom

• Leading State Life Sciences Associations Express Concerns with CMS’ Rule on Medicaid Value-Based Agreements

  7/20/2020

  BioNJ, Biocom, the California Life Sciences Association, the HINJ, LSPA, and the Michigan Biosciences Industry Association submitted comments to the CMS on a notice of proposed rulemaking impacting value-based purchasing agreements and other innovative solutions designed to provide patient access to, and purchasing agreements for, cutting edge therapies and cures.

• Biocom Supports California Life Science Companies with Best Practices Guide for Safely Returning to the Workplace

  5/29/2020

  Newly Available Publication Synthesizes Relevant Guidance from Multiple Federal and State Agencies

• AdvaMed and Biocom to Strategically Partner for The Digital MedTech Conference 2020

  2/10/2020

  Feb. 10, 2020 15:00 UTC The Digital MedTech Conference to showcase the growing and evolving digital medtech landscape WASHINGTON & SAN DIEGO--( BUSINESS WIRE )-- The Advanced Medical Technology Association (AdvaMed) and Biocom, the association representing the California life science industry, today announced a joint partnership to collaboratively produce The Digital MedTech Conference 2020. In combining Biocom’s DeviceFest and Digital Health Conference with AdvaMed’s D

• Biocom Condemns Passage of Innovation-Killing Drug Pricing Legislation

  12/12/2019

  Biocom, the association representing the life science industry of California, issued the following statement regarding the passage of H.R.3, the Lower Drug Costs Now Act, in the House of Representatives today

• Biocom Expresses Strong Concerns Over New USMCA Agreement Removing Essential Protections for Life-Saving Drugs

  12/11/2019

  Biocom, the association representing the life science industry of California, issued the following statement in response to the revised United States-Mexico-Canada Agreement deal unveiled yesterday by the Trump Administration.

• Biocom Appoints Karmin Noar as Executive Director of Biocom Institute

  12/4/2019

  In this role, she will oversee strategies, programs and staff and drive initiatives focused on STEM education and workforce development.

• New Data: Foreign Reference Pricing Proposal in H.R. 3 Would Slash Life-Saving R&D and Lead to Destruction of California’s Life Sciences Sector

  10/31/2019

  CLSA and Biocom Release Data Showing Anticipated Real-World Impact of Foreign Reference Pricing Proposed by House Democrats in H.R. 3 to Lower Drug Prices

• Biocom Announces Fourth Annual Catalyst Award Winners

  9/23/2019

  Biocom, the association representing the California life science industry, today announced the winners of its Fourth Annual Catalyst Awards

• Biocom Appoints Additional Members to Board of Directors from Bayer, KPMG and Procopio

  8/26/2019

  Judy Chou, Ph.D., senior vice president and global head of biotech/Berkeley site head, Bayer, Emad Fareed, partner at KPMG, and Bob Ramos, partner at Procopio, to its board of directors.

• 

  Los Angeles County Emerges as California's Third Biotech Hub, Report Shows

  6/10/2019

  California is well-known for its position in the biotech and pharma industry, with two world-class hubs in the Bay Area and the San Diego region. However, a new survey reveals the state is actually home to three significant hubs.

• Biocom Appoints Additional Members to Board of Directors

  5/29/2019

  Biocom, the association representing the California life science industry, today announced that it has added Matt Abernethy, chief financial officer of Neurocrine Biosciences, and Sabrina Martucci Johnson, president and chief executive officer of Daré Biosciences, to its board of directors.

• Dina Lozofsky, Executive Director of Biocom LA, Appointed to the Governing Board of BioLA

  4/25/2019

  BioLA was founded in 2018 to ensure Los Angeles has a collaborative, well-coalesced ecosystem that encompasses all aspects of the Southern California life sciences cluster.

• 

  Exclusive: Here’s What’s Happening in the California Life Sciences Job Market

  1/7/2019

  California’s life science sector is a major player in the state’s job creation and economic development. In 2016, life science companies in California employed more than 360,000 professionals.
• 

  Biotech Hires Go Beyond Lab Scientists, Report Shows

  11/10/2018

  Biotech companies need more than just researchers to ensure success. The most recent 2018 Talent Report issued by Biocom shows that 88 percent of California life science companies are planning on hiring over the next 12 months.

• Biocom and The CO Network to Host 3rd Annual Big Data Summit

  11/1/2018

  Biocom, the association representing the life science industry of California, and The CO Network, a culture technology company, today announced that they are hosting the 3rd Annual Big Data Summit at The Alexandria at Torrey Pines on Tuesday, November 6, 2018 from 8:15 am to 7:00 pm.

• Biocom Applauds Introduction of Rare Disease Fund Act

  9/18/2018

  Biocom, the association representing the life science industry of California, today applauded the introduction of H.R. 6801, the Rare Disease (RaD) Fund Act by U.S. Representatives Juan Vargas (D-CA), Scott Peters (D-CA) and Tom Rooney (R-FL).

• Biocom Opens San Francisco Bay Area Office and Forms Bay Area Advisory Board

  9/17/2018

  Biocom, the association representing the California life science industry, today announced the formation of a San Francisco Bay Area advisory board, as well as the grand opening of its Bay Area office.

• Biocom Endorses Nathan Fletcher for San Diego County 4th District Supervisorial Seat

  9/12/2018

  Biocom, the association representing the California life science industry, today announced the endorsement of Nathan Fletcher for the San Diego County Board of Supervisors District 4 seat.

• Biocom Appoints Two New Board Members and Adds to Its Executive Committee

  9/4/2018

  Biocom, the association representing the California life science industry, today announced the appointment of two new members to its board of directors: Deanne Calvert, J.D., head of state government relations for Sanofi US, and Ranjeet Banerjee, worldwide president of Medication Management Solutions for BD, a leading global medical technology company.

• Biocom Applauds House Passage of Legislation to Repeal the Medical Device Tax

  7/25/2018

  Biocom issued the following statement regarding the passage of H.R. 184, the Protect Medical Innovation Act, in the U.S. House of Representatives by a 283-132 vote.